Evaluation of efficacy and tolerability of glimepiride and metformin combination: a multicentric study in patients with type-2 diabetes mellitus, uncontrolled on monotherapy with sulfonylurea or metformin.

Keywords : ["diabetes mellitus uncontrolle", "multicentric study", "metformin combination", "metformin", "tolerability", "sulfonylurea", "patient", "monotherapy", "glimepiride", "evaluation", "efficacy"]
Author : Fist_Author_Year_PM
95

Multimodal approaches of the hydroalcoholic extract of Diospyros peregrina fruits in diabetic therapy.

Keywords : ["diospyro peregrina fruit", "multimodal approach", "hydroalcoholic extract", "diabetic therapy"]
Author : Fist_Author_Year_PM
32

Recovery of beta-cell functions with low-dose insulin therapy: study in newly diagnosed type 2 diabetes mellitus patients.

Keywords : ["newly diagnose type diabetes mellitus patient", "lowdose insulin therapy study", "betacell function", "recovery"]
Author : Fist_Author_Year_PM
31

One year of liraglutide treatment offers sustained and more effective glycaemic control and weight reduction compared with sitagliptin, both in combination with metformin, in patients with type 2 diabetes: a randomised, parallel-group, open-label trial.

Keywords : ["randomised parallelgroup openlabel trial", "liraglutide treatment offer sustain", "weight reduction compare", "effective glycaemic control", "type diabetes", "one year", "sitagliptin", "patient", "metformin", "combination"]
Author : Fist_Author_Year_PM
94

Antioxidant potential of n-butanol fraction from extract of Jasminum mesnyi Hance leaves.

Keywords : ["jasminum mesnyi hance leave", "nbutanol fraction", "antioxidant potential", "extract"]
Author : Fist_Author_Year_PM
48

Hypoglycemic activity of C-glycosyl flavonoid from Enicostemma hyssopifolium.

Keywords : ["hypoglycemic activity", "enicostemma hyssopifolium", "cglycosyl flavonoid"]
Author : Fist_Author_Year_PM
31

Insulin degludec, an ultra-long-acting basal insulin, once a day or three times a week versus insulin glargine once a day in patients with type 2 diabetes: a 16-week, randomised, open-label, phase 2 trial.

Keywords : ["randomise openlabel phase trial", "week versus insulin glargine", "ultralongacting basal insulin", "insulin degludec", "type diabetes", "three time", "patient", "day", "day"]
Author : Fist_Author_Year_PM
100

Glycaemic control and the risk of mortality in elderly type 2 diabetic patients (ZODIAC-20).

Keywords : ["elderly type diabetic patient", "glycaemic control", "risk", "mortality"]
Author : Fist_Author_Year_PM
31

Protective effects of enalapril in streptozotocin-induced diabetic rat: studies of DNA damage, apoptosis and expression of CCN2 in the heart, kidney and liver.

Keywords : ["streptozotocininduce diabetic rat study", "dna damage apoptosis", "protective effect", "heart kidney", "liver", "expression", "enalapril"]
Author : Fist_Author_Year_PM
47

Dual therapy versus monotherapy of trandolapril and telmisartan on diabetic nephropathy in experimentally induced type 2 diabetes mellitus rats.

Keywords : ["experimentally induce type diabetes mellitus rat", "dual therapy versus monotherapy", "diabetic nephropathy", "trandolapril", "telmisartan"]
Author : Fist_Author_Year_PM
75